Condition

Alopecia Areata clinical trials and research

• 27Clinical trials
• 8NIH research projects
• 1New in 30 days
• 37Countries

Newest Alopecia Areata clinical trials

All recruiting trials (27)

• Which works better for patchy hair loss: steroid injections or microneedling with steroid cream?

  This trial tests whether injecting triamcinolone into the skin or using microneedling with topical triamcinolone helps people with alopecia areata regrow hair more effectively.

  Recruiting Phase 4 Dow University of Health Sciences · Karachi, Sindh · NCT07926711

• Red Ultraviolet Hair Imaging and Hair Growth in Alopecia Areata

  This observational study checks if red fluorescence seen with UV hair imaging relates to disease features and how well hair regrows after standard intralesional corticosteroid treatment in adults with limited plaque-type alopecia areata.

  Recruiting Istanbul Training and Research Hospital · Istanbul · NCT07803874

• VC005 tablets in teens with severe alopecia areata

  This Phase 1 study tests VC005 tablets in adolescents with severe alopecia areata to see how the drug behaves in the body, whether it is safe, and if there are signs of benefit.

  Recruiting Phase 1 Jiangsu vcare pharmaceutical technology co., LTD · Beijing, Beijing Municipality · NCT07762443

• VC005 tablets in severe alopecia areata

  This study tests whether VC005 tablets work better than a placebo for adults with severe alopecia areata.

  Recruiting Phase 2 Jiangsu vcare pharmaceutical technology co., LTD · Beijing, Beijing Municipality · NCT07749716

• Ritlecitinib for patchy hair loss in teens and adults with alopecia areata

  This study tests whether ritlecitinib can help people 12 and older with patchy alopecia areata who have had symptoms for 6 months to 10 years.

  Recruiting at 30 sites Phase 3 Pfizer · Encinitas, California and 37 other locations · NCT07733765

• Alopecia Areata: looking at ferroptosis markers in blood

  This study tests whether levels of GPX4 and MDA in blood differ between people with alopecia areata and healthy controls.

  Recruiting Istanbul Training and Research Hospital · Istanbul, Cerrahpasa Mahallesi · NCT07733063

• Deuruxolitinib in Japanese Adults With Severe Alopecia Areata

  This study tests whether deuruxolitinib can help Japanese adults with 50% or more scalp hair loss compare to placebo.

  Recruiting at 17 sites Phase 3 Sun Pharma Japan Limited · Asahikawa and 17 other locations · NCT07617597

• LY4005130 for adults with severe alopecia areata (hair loss)

  This trial tests whether intravenous LY4005130 helps adults with severe alopecia areata regrow scalp hair compared with placebo while monitoring safety and side effects.

  Recruiting at 30 sites Phase 2 Eli Lilly and Company · Fremont, California and 29 other locations · NCT07533006

• LAD603 treatment for adults with severe to very severe alopecia areata

  This trial will test whether LAD603 can help adults with severe to very severe alopecia areata regrow scalp hair.

  Recruiting Phase 2 Almirall, S.A. · Omaha, Nebraska · NCT07311564

• PALLAS 311 nm UVB laser treatment for vitiligo, psoriasis, alopecia areata, and atopic dermatitis

  This study will test the PALLAS 311 nm UVB laser as an in-clinic, twice-weekly treatment for adults with vitiligo, psoriasis, alopecia areata, or atopic dermatitis for up to three months.

  Recruiting Szeged University · Szeged, Csongrád-Csanád Vármegye · NCT07250997

• Abrocitinib for eczema and patchy hair loss in people with Down syndrome

  This trial will test whether taking abrocitinib daily can help improve eczema or patchy hair loss in people with Down syndrome aged 12 and up.

  Recruiting Phase 2 Icahn School of Medicine at Mount Sinai · New York, New York · NCT07242638

• FB102 treatment for adults with severe to very severe alopecia areata

  This trial tests whether the medication FB102 can help adults with severe to very severe alopecia areata regrow hair and is safe compared with a placebo.

  Recruiting Phase 1 Forte Biosciences, Inc. · Saint Leonards, New South Wales (nsw) and 5 other locations · NCT07205159

• Global assessment of disease burden in adolescents and adults with alopecia areata, vitiligo, or hidradenitis suppurativa

  This project will see if collecting real-world information from adolescents and adults with moderate or severe alopecia areata, non-segmental vitiligo, or hidradenitis suppurativa can describe their disease burden worldwide.

  Recruiting at 116 sites AbbVie · Ciudad Autonoma de Buenos Aire, Buenos Aires and 115 other locations · NCT07136467

• Deuruxolitinib for adolescents with severe alopecia areata

  This trial will see if deuruxolitinib can safely help adolescents aged 12 to 17 who have lost at least half their scalp hair from alopecia areata.

  Recruiting at 64 sites Phase 3 Sun Pharmaceutical Industries Limited · Birmingham, Alabama and 63 other locations · NCT07133308

• Testing two doses of ritlecitinib for treating alopecia areata in people aged 12 and older

  This study is testing two different doses of a new oral medication called ritlecitinib to see if it can help people aged 12 and older with significant hair loss from alopecia areata.

  Recruiting at 41 sites Phase 3 Pfizer · Birmingham, Alabama and 147 other locations · NCT06873945

• Microbiota transplant to treat hair loss from alopecia areata

  This will try a short course of antibiotics followed by an oral microbiota transplant to see if adults with moderate-to-severe alopecia areata can regrow hair.

  Recruiting Phase 2 University of Minnesota · Minneapolis, Minnesota · NCT06747611

• Evaluating the effectiveness and safety of JAK inhibitors for alopecia areata

  This study is testing how well and safely JAK inhibitors work for kids and teens with alopecia areata who have been using them for at least three months.

  Recruiting Second Affiliated Hospital, Zhejiang University, School of Medicine · Hangzhou, Zhejiang · NCT06573593

• Registry for adolescents with severe alopecia areata

  This study is tracking adolescents with severe alopecia areata to see how well their treatments work and to understand their condition better over time.

  Recruiting CorEvitas · Waltham, Massachusetts · NCT06562270

• Microneedling with different treatments for hair loss

  This study is testing whether microneedling combined with different treatments can help people with alopecia areata grow their hair back.

  Recruiting Zagazig University · Zagazig · NCT06327581

• Registry for systemic treatments of alopecia areata

  This study is trying to see how well different systemic treatments work for people with moderate-to-severe alopecia areata, alopecia totalis, and alopecia universalis.

  Recruiting Erasmus Medical Center · Rotterdam · NCT06283316

• Evaluating NXC-736 for treating moderate to severe alopecia areata

  This study is testing if an oral medication called NXC-736 can help adults with moderate to severe alopecia areata regrow their hair and improve their quality of life.

  Recruiting at 2 sites Phase 2 NEXTGEN Bioscience · Seoul and 1 other locations · NCT06104839

• Upadacitinib tablets for severe alopecia areata in adolescents and adults

  This trial will try upadacitinib tablets to see if they are safe and help regrow hair in adolescents and adults with severe alopecia areata.

  Recruiting at 46 sites Phase 3 AbbVie · Birmingham, Alabama and 271 other locations · NCT06012240

• Understanding the factors influencing chronic inflammatory skin diseases

  This study is trying to understand what causes different types of chronic skin conditions, like eczema and psoriasis, to behave differently in patients over time.

  Recruiting University Hospital Schleswig-Holstein · Kiel · NCT05928169

• Using Dupilumab to treat children with Alopecia Areata

  This study is testing if Dupilumab can help children and teens with moderate to severe Alopecia Areata grow their hair back.

  Recruiting at 5 sites Phase 2 Icahn School of Medicine at Mount Sinai · Irvine, California and 4 other locations · NCT05866562

• Registry for safety and effectiveness of alopecia areata treatments

  This study is trying to collect information from about 5,000 people with alopecia areata to see how safe and effective different treatments are over time.

  Recruiting CorEvitas · Waltham, Massachusetts · NCT05745389

• Treatment for moderate to severe alopecia areata using dupilumab

  This study is testing if a medication called dupilumab can help people with moderate to severe alopecia areata, which causes significant hair loss, to regrow their hair.

  Recruiting at 3 sites Phase 2 Icahn School of Medicine at Mount Sinai · Irvine, California and 2 other locations · NCT05551793

• Evaluating Ruxolitinib for Hair Regrowth in APECED-Associated Alopecia Areata

  This study is testing if a medication called ruxolitinib can help people aged 12 to 65 with a rare autoimmune condition and severe hair loss to regrow their hair and improve other symptoms.

  Recruiting Phase 2 National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT05398809

NIH-funded research (8)

Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.

• Dupilumab for hair regrowth in children with alopecia areata

  This project gives dupilumab to children and teens with widespread alopecia areata, especially those with allergies or high IgE, to help their hair grow back.

  NIH research Icahn School of Medicine at Mount Sinai · New York, United States · NIH-11322610

• Targeting the NKG2A immune pathway to treat alopecia areata

  This project will try blocking the NKG2A immune signal to reduce the immune attack on hair follicles and help people with alopecia areata regrow hair.

  NIH research Columbia University Health Sciences · New York, United States · NIH-11294331

• How IL-27 affects hair loss in alopecia areata

  Researchers are exploring whether the immune molecule IL-27 helps stop the immune attack that causes hair loss in people with alopecia areata.

  NIH research University of Iowa · Iowa City, United States · NIH-11177806

• Using hydrogels to treat hair loss in alopecia areata

  This study is exploring a new gel treatment for people with alopecia areata, a condition that causes hair loss, to see if it can help stimulate hair regrowth in a safe and effective way.

  NIH research University of Pennsylvania · Philadelphia, United States · NIH-11136601

• Using dupilumab to treat hair loss in children with alopecia areata

  This study is looking at how a medication called dupilumab can help kids with alopecia areata, a condition that causes hair loss, by encouraging hair regrowth and making sure the treatment is safe and effective for them.

  NIH research Icahn School of Medicine at Mount Sinai · New York, United States · NIH-11089294

• Investigating the NKG2A pathway to treat hair loss in alopecia areata

  This study is looking at alopecia areata, a condition that causes hair loss, and is exploring new ways to help by targeting certain immune cells; if you're dealing with this condition, you might have a chance to join trials testing these exciting new treatments.

  NIH research Columbia University Health Sciences · New York, United States · NIH-11051236

• Investigating the role of IL-27 in hair loss caused by autoimmune disease

  This study is looking at how a substance called IL-27 affects the immune system in people with alopecia areata, a condition that causes hair loss, to find new ways to help treat it.

  NIH research University of Iowa · Iowa City, United States · NIH-10907675

• How Gut Bacteria Affect Hair Loss in Alopecia Areata

  This project explores how the bacteria in our gut might influence the progression of alopecia areata, a condition that causes hair loss.

  NIH research Columbia University Health Sciences · New York, United States · NIH-10814252

Related topics

Quick answers

How many Alopecia Areata clinical trials are recruiting right now?

27, as of November 12, 2026. 1 of them was first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 37 countries. The most sites are in United States (13 trials), China (7 trials), Canada (6 trials), South Korea (6 trials), Japan (5 trials). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 9, Phase 3: 5, Phase 1: 2, Phase 4: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →